Smith BD - Search Results

1

CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.

Ding H, Vincelette ND, McGehee CD, Kohorst MA, Koh BD, Venkatachalam A, Meng XW, Schneider PA, Flatten KS, Peterson KL, Correia C, Lee SH, Patnaik M, Webster JA, Ghiaur G, Smith BD, Karp JE, Pratz KW, Li H, Karnitz LM, Kaufmann SH. Ding H, et al. Among authors: smith bd. Cancer Res. 2021 May 15;81(10):2666-2678. doi: 10.1158/0008-5472.CAN-20-1504. Epub 2021 Jan 7. Cancer Res. 2021. PMID: 33414171 Free PMC article.

2

BP1, a new homeobox gene, is frequently expressed in acute leukemias.

Haga SB, Fu S, Karp JE, Ross DD, Williams DM, Hankins WD, Behm F, Ruscetti FW, Chang M, Smith BD, Becton D, Raimondi SC, Berg PE. Haga SB, et al. Among authors: smith bd. Leukemia. 2000 Nov;14(11):1867-75. doi: 10.1038/sj.leu.2401912. Leukemia. 2000. PMID: 11069021

3

The role of growth factors in the activity of pharmacological differentiation agents.

Matsui WH, Gladstone DE, Vala MS, Barber JP, Brodsky RA, Smith BD, Jones RJ. Matsui WH, et al. Among authors: smith bd. Cell Growth Differ. 2002 Jun;13(6):275-83. Cell Growth Differ. 2002. PMID: 12114217

4

Response to 'comparison of "sequential" versus "standard" chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial'.

Smith BD, Karp J, Burke P. Smith BD, et al. Br J Haematol. 2003 Jul;122(1):164-5. doi: 10.1046/j.1365-2141.2003.04395_5.x. Br J Haematol. 2003. PMID: 12823362 Free article. No abstract available.

5

Ribonucleotide reductase: an old target with new potential.

Smith BD, Karp JE. Smith BD, et al. Leuk Res. 2003 Dec;27(12):1075-6. doi: 10.1016/s0145-2126(03)00248-0. Leuk Res. 2003. PMID: 12921942 No abstract available.

6

Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.

Mesa RA, Loegering D, Powell HL, Flatten K, Arlander SJ, Dai NT, Heldebrant MP, Vroman BT, Smith BD, Karp JE, Eyck CJ, Erlichman C, Kaufmann SH, Karnitz LM. Mesa RA, et al. Among authors: smith bd. Blood. 2005 Jul 1;106(1):318-27. doi: 10.1182/blood-2004-09-3523. Epub 2005 Mar 22. Blood. 2005. PMID: 15784732 Free PMC article.

7

Trying to improve clinical outcome in AML: lessons from negative trials.

Karp JE, Smith BD. Karp JE, et al. Among authors: smith bd. Leuk Res. 2005 Jun;29(6):603-4. doi: 10.1016/j.leukres.2004.12.013. Epub 2005 Mar 16. Leuk Res. 2005. PMID: 15863196 No abstract available.

8

Curing acute myelogenous leukemia: still a major challenge.

Smith BD, Karp JE. Smith BD, et al. Leuk Res. 2005 Jun;29(6):607-8. doi: 10.1016/j.leukres.2004.11.026. Epub 2005 Mar 29. Leuk Res. 2005. PMID: 15863198 No abstract available.

9

Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.

Gore SD, Smith BD, Gojo I, Grever M, Kaufmann SH, Letendre L, Leonard DG, Marcucci G, Miller CB, Morris L, Piantadosi S, Prior T, Stock W, Karp JE. Gore SD, et al. Among authors: smith bd. Am J Hematol. 2005 Jun;79(2):119-27. doi: 10.1002/ajh.20354. Am J Hematol. 2005. PMID: 15929100 Free article.

10

The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.

Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt M, Huso DL, Dang CV. Osthus RC, et al. Among authors: smith bd. Cancer Res. 2005 Jul 1;65(13):5620-7. doi: 10.1158/0008-5472.CAN-05-0536. Cancer Res. 2005. PMID: 15994934 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,097 results

Search Page